Cd8+Foxp3+cells represent early, effector T-cells and predict outcomes in patients with resectable non-small cell lung carcinoma (NSCLC) receiving neoadjuvant anti-PD-1-based therapy Meeting Abstract
| Authors: | Cohen, E.; Wang, D.; Engle, E.; Green, B.; Caushi, J.; Zhang, J.; Sunshine, J.; Uttam, S.; Fotheringham, M.; Fiorante, A.; Espinosa, N.; Pandey, B.; Popa, T.; Ogurtsova, A.; SotoDiaz, S.; Loyola, J.; Roskes, J.; Eminizer, M.; Medvedev, D.; Chaft, J.; Brahmer, J.; Reuss, J.; Forde, P.; Szalay, A.; Pardoll, A.; Smith, K.; Taube, J.; Cottrell, T. |
| Abstract Title: | Cd8+Foxp3+cells represent early, effector T-cells and predict outcomes in patients with resectable non-small cell lung carcinoma (NSCLC) receiving neoadjuvant anti-PD-1-based therapy |
| Meeting Title: | 37th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2022) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 10 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2022 Nov 8-12 |
| Meeting Location: | Boston, MA |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2022-11-01 |
| Start Page: | A63 |
| Language: | English |
| ACCESSION: | WOS:000919423400058 |
| DOI: | 10.1136/jitc-2022-SITC2022.0057 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 57 -- Source: Wos |
